Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship
- PMID: 32589577
- PMCID: PMC7319098
- DOI: 10.7812/TPP/19.129
Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship
Abstract
Patients with a current diagnosis of breast cancer are enjoying dramatic cure rates and survivorship secondary to an increase in awareness, earlier detection, and more effective therapies. Although strategies such as Breast Cancer Awareness Month in October focus on early detection, lifestyle changes are seldom discussed other than dietary concerns and physical activity. Lifestyle modifications centered on diet and exercise have been demonstrated to affect overall disease-free survival in breast cancer. Since the early 2000s, the role of the human gut microbiota and its relation to breast cancer has become a major area of interest in the scientific and medical community. We live and survive owing to the symbiotic relationship with the microorganisms within us: the human microbiota. Scientific advances have identified a subset of the gut microbiota: the estrobolome, those bacteria that have the genetic capability to metabolize estrogen, which plays a key role in most breast cancers. Recent research provides evidence that the gut microbiome plays a substantial role in estrogen regulation. Gut microbiota diversity appears to be an essential component of overall health, including breast health. Future research attention should include a more extensive focus on the role of the human gut microbiota in breast cancer.
Conflict of interest statement
The author(s) have no conflicts of interest to disclose.
Figures
References
Sidebar References
References
-
- Breast cancer facts and figures 2017–2018. Atlanta GA: American Cancer Society; 2017.
-
- Global Burden of Disease Cancer Collaboration. Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990–2015. A systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017 Apr 1;3(4):524–48. doi: 10.1001/jamaoncol.2016.5688. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
